Updated Jul 16, 2026
Allen Patricia L has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $500K. Historical track record: 1/5 stars across 4 tracked purchases.
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★☆☆☆☆ (1/5) |
|---|---|
| Total purchases tracked | 4 |
| Purchases with forward-return data | 4 |
| 30-day win rate | 0% |
| 90-day win rate | 0% |
| Avg 5-day return | +216.10% |
| Avg 30-day return | -1127.46% |
| Avg 90-day return | -2485.41% |
| Best 30-day return | -1103.03% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-13 | ZBIO | Zenas BioPharma, Inc. | P — Open-market purchase | 4.2K | $26.36 | $110K |
| 2026-02-13 | ZBIO | Zenas BioPharma, Inc. | P — Open-market purchase | 5.0K | $26.50 | $132K |
| 2026-02-13 | ZBIO | Zenas BioPharma, Inc. | P — Open-market purchase | 5.7K | $24.34 | $139K |
| 2026-02-13 | ZBIO | Zenas BioPharma, Inc. | P — Open-market purchase | 5.0K | $23.77 | $119K |
Allen Patricia L is a corporate insider — currently tracked as Director of Zenas BioPharma, Inc. (ZBIO). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 4 open-market purchases ($500K) and 0 open-market sales () across all tracked filings.
Across 4 tracked purchases, Allen Patricia L averaged -1127.5% avg 30-day return with a 0% 30-day win rate. InsiderAlpha rates the track record at 1/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Allen Patricia L profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.